Journal of clinical anesthesia
-
Randomized Controlled Trial
Dexmedetomidine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular response to tracheal intubation.
To evaluate the effect of dexmedetomidine combined with fentanyl on hemodynamics. ⋯ Dexmedetomidine combined with fentanyl during anesthetic induction suppresses the decrease in blood pressure due to anesthetic induction and also blunts the cardiovascular response to tracheal intubation.
-
To evaluate patient satisfaction at discharge and 30 days after day surgery, and to identify predictive factors of patient satisfaction. ⋯ Overall satisfaction following day surgery was at least 95% at discharge and at 30 days. However, complete satisfaction was present only in 75% at discharge and decreased to 62% at 30 days. Clinical outcome was strongly related to patient satisfaction at 30 days after surgery. Factors directly controlled by anesthesiologists such as postoperative pain and information provided, also had a significant impact on patient satisfaction.
-
Randomized Controlled Trial Comparative Study
The comparative effects of equipotent Bispectral Index dosages of propofol and sevoflurane on cerebrovascular carbon dioxide reactivity in elderly patients.
To compare the effects of equipotent Bispectral Index (BIS) doses of propofol and sevoflurane on cerebrovascular carbon dioxide (CO(2)) reactivity in elderly patients. ⋯ In elderly patients, hypercapnia has less effect on cerebral circulation during propofol anesthesia than with sevoflurane.
-
Review Case Reports
Dexmedetomidine for deep brain stimulator placement in a child with primary generalized dystonia: case report and literature review.
Dexmedetomidine, which is a relatively selective alpha2-adrenoceptor agonist, is used for sedation and analgesia in intensive care unit patients, during awake craniotomies in pediatric and adult patients, and during magnetic resonance imaging, with minimal depression of respiratory function. The successful use of dexmedetomidine in a pediatric patient undergoing bilateral deep brain stimulator placement for the treatment of generalized dystonia, is presented.